May 26, 2021
Today, the increasing prevalence of Chronic Respiratory Diseases (CRDs) is one of the leading health challenges worldwide. CRDs affect hundreds of millions of people and cause huge mortality, morbidity, immense socio-economic burden, and disability-adjusted life years (DALYs). Over the past few decades, si...
Read More...
May 12, 2021
Over the past three-four decades, there has been a significant increase in the number of morbidity and mortality due to asthma. As per the WHO’s 2019 data, an estimated 262 million people worldwide were affected by asthma and caused nearly 4,61,000 deaths. The low- and lower-middle-income countries registered the m...
Read More...
May 27, 2020
As per WHO, “Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer”. The patients whose lives are afflicted with similar types of cancers have long been administered a similar type of treatment regimen b...
Read More...
Apr 29, 2020
The development of telecommunications and web technologies over the past few decades has brought a revolutionary change in almost every industry. Healthcare industry is no exception to this change. Each day a new application of the internet is in use for better healthcare information and healthcare service del...
Read More...
Feb 19, 2020
Cardiovascular diseases (CVDs) are one of the leading causes of death and health loss in people in the US. As per a study by the National Vital Statistics Report, every 37 seconds, one person dies of Cardiovascular diseases in the US. Cardiovascular diseases also known as heart disease, encompasses a wide range...
Read More...
Feb 06, 2020
Activated immune cells responsible for improving age-related diseases The main culprits of the inflammatory responses associated with asthma are Interleukins IL-33 and IL-5. There has been researching going on, and the researchers at Albany Medical College discovered that if these two signalling molecules ...
Read More...
Jan 30, 2020
A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has managed to net USD 2 million more by offering 40% more shares. The company plans to use the funds raised to address the unmet needs in the Alzheimer’s disease market...
Read More...
Jan 29, 2020
The 21st century has been a remarkable century for humankind, as a lot of innovation, research and development has taken place in the field of healthcare, due to which we have been able to increase the overall lifespan of the human beings. However, the central question is, are we able to increase the healt...
Read More...
Dec 26, 2019
An allergy is a response produced by the body’s immune system to any foreign substance which is not usually harmful. These foreign substances can be anything ranging from food products such as peanuts, egg, lactose, or pollen grains, dust particles, or pet dander. There are several forms of allergies such ...
Read More...
May 21, 2019
FDA approves Fragmin- an anticoagulant for children The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the d...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper